Swiss National Bank
EVH icon

Swiss National Bank’s Evolent Health EVH Stock Holding History

Swiss National Bank’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-193,400
Closed -$774K – 2321
2025
Q4 		$774K Hold
193,400
– – ﹤0.01% 2241
2025
Q3 		$1.64M Buy
193,400
+4,100
+2% +$39.8K ﹤0.01% 1947
2025
Q2 		$2.13M Sell
189,300
-3,600
-2% -$33.1K ﹤0.01% 1779
2025
Q1 		$1.83M Hold
192,900
– – ﹤0.01% 1819
2024
Q4 		$2.17M Hold
192,900
– – ﹤0.01% 1805
2024
Q3 		$5.46M Sell
192,900
-11,300
-6% -$291K ﹤0.01% 1277
2024
Q2 		$3.9M Hold
204,200
– – ﹤0.01% 1421
2024
Q1 		$6.7M Sell
204,200
-7,800
-4% -$249K ﹤0.01% 1116
2023
Q4 		$7M Sell
212,000
-23,300
-10% -$659K 0.01% 1077
2023
Q3 		$6.41M Buy
235,300
+17,700
+8% +$492K 0.01% 1123
2023
Q2 		$6.59M Buy
217,600
+32,000
+17% +$1.03M ﹤0.01% 1142
2023
Q1 		$6.02M Sell
185,600
-13,600
-7% -$430K ﹤0.01% 1136
2022
Q4 		$5.59M Buy
199,200
+14,600
+8% +$419K ﹤0.01% 1251
2022
Q3 		$6.63M Buy
184,600
+2,700
+1% +$95.1K ﹤0.01% 1114
2022
Q2 		$5.59M Sell
181,900
-29,500
-14% -$860K ﹤0.01% 1246
2022
Q1 		$6.83M Buy
211,400
+19,300
+10% +$505K ﹤0.01% 1246
2021
Q4 		$5.32M Hold
192,100
– – ﹤0.01% 1425
2021
Q3 		$5.96M Buy
192,100
+3,000
+2% +$72K ﹤0.01% 1341
2021
Q2 		$3.99M Buy
189,100
+12,700
+7% +$254K ﹤0.01% 1653
2021
Q1 		$3.56M Buy
176,400
+2,000
+1% +$38K ﹤0.01% 1666
2020
Q4 		$2.8M Hold
174,400
– – ﹤0.01% 1722
2020
Q3 		$2.16M Buy
174,400
+3,700
+2% +$43.5K ﹤0.01% 1678
2020
Q2 		$1.22M Buy
170,700
+24,200
+17% +$162K ﹤0.01% 1992
2020
Q1 		$795K Buy
146,500
+2,000
+1% +$17.9K ﹤0.01% 1964
2019
Q4 		$1.31M Buy
144,500
+5,900
+4% +$47.9K ﹤0.01% 1985
2019
Q3 		$997K Buy
138,600
+7,400
+6% +$53.1K ﹤0.01% 2058
2019
Q2 		$1.04M Buy
131,200
+24,100
+23% +$285K ﹤0.01% 2094
2019
Q1 		$1.35M Buy
107,100
+3,800
+4% +$60.2K ﹤0.01% 1898
2018
Q4 		$2.06M Buy
103,300
+2,500
+2% +$57.8K ﹤0.01% 1550
2018
Q3 		$2.86M Buy
100,800
+3,300
+3% +$78.7K ﹤0.01% 1480
2018
Q2 		$2.05M Sell
97,500
-6,500
-6% -$123K ﹤0.01% 1691
2018
Q1 		$1.48M Buy
104,000
+4,800
+5% +$68.7K ﹤0.01% 1834
2017
Q4 		$1.22M Hold
99,200
– – ﹤0.01% 1967
2017
Q3 		$1.77M Buy
99,200
+11,800
+14% +$243K ﹤0.01% 1698
2017
Q2 		$2.22M Buy
87,400
+26,400
+43% +$635K ﹤0.01% 1521
2017
Q1 		$1.36M Buy
61,000
+20,800
+52% +$399K ﹤0.01% 1823
2016
Q4 		$595K Sell
40,200
-3,600
-8% -$70.9K ﹤0.01% 2317
2016
Q3 		$1.08M Buy
43,800
+10,900
+33% +$255K ﹤0.01% 1915
2016
Q2 		$632K Buy
32,900
+15,600
+90% +$214K ﹤0.01% 2224
2016
Q1 		$175K Buy
17,300
+4,200
+32% +$43.4K ﹤0.01% 2570
2015
Q4 		$159K Buy
+13,100
New +$193K ﹤0.01% 2607

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Swiss National Bank's EVH Position: Q1 2026 in Review

Swiss National Bank sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 193,400 shares — an estimated $774K sold.

Swiss National Bank first reported a position in EVH in Q4 2015 and held it in 41 quarters. The position peaked at $7M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Swiss National Bank reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Swiss National Bank sold 193,400 Evolent Health shares in Q1 2026, an estimated $774K.
  • Swiss National Bank first reported a position in Evolent Health in Q4 2015 and held it in 41 quarters.
  • Swiss National Bank's Evolent Health position peaked at $7M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.